CA3189526A1 - Adhesion-preventing agent and method for preventing adhesion using same - Google Patents

Adhesion-preventing agent and method for preventing adhesion using same

Info

Publication number
CA3189526A1
CA3189526A1 CA3189526A CA3189526A CA3189526A1 CA 3189526 A1 CA3189526 A1 CA 3189526A1 CA 3189526 A CA3189526 A CA 3189526A CA 3189526 A CA3189526 A CA 3189526A CA 3189526 A1 CA3189526 A1 CA 3189526A1
Authority
CA
Canada
Prior art keywords
anionized
adhesion preventing
adhesion
preventing agent
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3189526A
Other languages
English (en)
French (fr)
Inventor
Atsushi Ohhata
Hiromichi Yamashita
Shiori FUJIMOTO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Factory Inc
Original Assignee
Otsuka Pharmaceutical Factory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Factory Inc filed Critical Otsuka Pharmaceutical Factory Inc
Publication of CA3189526A1 publication Critical patent/CA3189526A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Composite Materials (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Sealing Material Composition (AREA)
  • Paints Or Removers (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
CA3189526A 2020-06-01 2021-06-01 Adhesion-preventing agent and method for preventing adhesion using same Pending CA3189526A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020095280 2020-06-01
JP2020-095280 2020-06-01
PCT/JP2021/020791 WO2021246388A1 (ja) 2020-06-01 2021-06-01 癒着防止剤及びそれを用いた癒着防止方法

Publications (1)

Publication Number Publication Date
CA3189526A1 true CA3189526A1 (en) 2021-12-09

Family

ID=78831085

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3189526A Pending CA3189526A1 (en) 2020-06-01 2021-06-01 Adhesion-preventing agent and method for preventing adhesion using same

Country Status (13)

Country Link
US (1) US20230226098A1 (https=)
EP (1) EP4159251A4 (https=)
JP (2) JP7321610B2 (https=)
KR (1) KR20230018490A (https=)
CN (1) CN115884800A (https=)
AR (1) AR122491A1 (https=)
AU (1) AU2021284433A1 (https=)
BR (1) BR112022022193A2 (https=)
CA (1) CA3189526A1 (https=)
MX (1) MX2022015193A (https=)
TW (1) TW202210113A (https=)
WO (1) WO2021246388A1 (https=)
ZA (1) ZA202211627B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7832428B2 (ja) * 2021-02-26 2026-03-18 国立大学法人信州大学 表面修飾多糖類ナノ材料、その分散液、機能性物品及び機能性物品の加工法
CN114904053A (zh) * 2022-05-31 2022-08-16 重庆大学 一种基于纤维素纳米晶的抗炎防组织粘连生物涂层及其制备方法和应用
DE102023116601A1 (de) 2022-06-29 2024-01-04 Semiconductor Energy Laboratory Co., Ltd. Licht emittierende Vorrichtung

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610669B1 (en) * 1987-09-18 2003-08-26 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
DE69015775T2 (de) * 1989-10-31 1995-05-11 Howmedica Chitinderivate enthaltende Zusammensetzungen zur Verhütung der Adhäsion.
JP3545790B2 (ja) 1993-09-30 2004-07-21 味の素ファルマ株式会社 腹腔内の癒着防止剤
WO2005000374A1 (ja) * 2003-06-30 2005-01-06 Denki Kagaku Kogyo Kabushiki Kaisha 脊椎・脊髄手術用癒着防止材
JP4998981B2 (ja) 2006-06-20 2012-08-15 国立大学法人 東京大学 微細セルロース繊維
JP5001246B2 (ja) 2008-09-26 2012-08-15 古河電池株式会社 蓄電池用モノブロック電槽
RU2012146357A (ru) * 2010-03-31 2014-05-10 Хоги Медикал Ко., Лтд. Предотвращающий адгезию материал
WO2013047218A1 (ja) * 2011-09-30 2013-04-04 日本製紙株式会社 セルロースナノファイバーの製造方法
JP6199858B2 (ja) * 2012-03-14 2017-09-20 日本製紙株式会社 アニオン変性セルロースナノファイバー分散液の製造方法
JP5921960B2 (ja) 2012-06-04 2016-05-24 第一工業製薬株式会社 無機微粒子含有組成物およびそれを用いた被膜
EP2998435B1 (en) 2013-05-16 2021-10-13 Oji Holdings Corporation Phosphoric acid esterified cellulose fibers and production method thereof
JP2015099083A (ja) 2013-11-19 2015-05-28 三菱重工業株式会社 酸露点腐食評価装置及び酸露点腐食評価方法
WO2015099083A1 (ja) * 2013-12-25 2015-07-02 日産化学工業株式会社 血清および血液を固化する水分散液
JP2017155024A (ja) 2016-03-04 2017-09-07 株式会社ユーグレナ 細胞増殖促進剤
KR102232614B1 (ko) 2016-07-21 2021-03-29 난징 산홈 팔마세우티칼 컴퍼니 리미티드 이소시트레이트 탈수소효소 억제제의 화학적 화합물 및 이의 적용
CA3049855C (en) 2017-01-16 2022-06-14 Kri, Inc. Sulfuric acid esterification modified cellulose nanofibers and method for producing cellulose nanofibers
JP6958799B2 (ja) * 2017-05-25 2021-11-02 日本製紙株式会社 ハイドロゲル
CN110520448B (zh) 2017-06-16 2023-04-07 东亚合成株式会社 纤维素纳米纤维的制造方法
KR102031178B1 (ko) * 2017-07-14 2019-10-11 순천향대학교 산학협력단 주입형 온도감응성 목재 기반 산화 나노 셀룰로오스를 포함한 유착 방지제
SI3533458T1 (sl) * 2018-03-02 2023-09-29 Upm-Kymmene Corporation Medicinski izdelek, ki vsebuje bioaktivno molekulo, ki je imobilizirana na nanofibrilarno celulozo in postopek za njegovo pripravo
CN109966540B (zh) * 2019-04-04 2020-06-23 武汉大学 一种纳米甲壳素复合海藻酸钙医用敷料的制备方法及应用

Also Published As

Publication number Publication date
KR20230018490A (ko) 2023-02-07
AR122491A1 (es) 2022-09-14
JP7321610B2 (ja) 2023-08-07
EP4159251A4 (en) 2024-06-19
US20230226098A1 (en) 2023-07-20
TW202210113A (zh) 2022-03-16
JPWO2021246388A1 (https=) 2021-12-09
MX2022015193A (es) 2023-01-04
EP4159251A1 (en) 2023-04-05
BR112022022193A2 (pt) 2022-12-13
JP2023096193A (ja) 2023-07-06
AU2021284433A1 (en) 2022-12-01
WO2021246388A1 (ja) 2021-12-09
ZA202211627B (en) 2024-02-28
CN115884800A (zh) 2023-03-31

Similar Documents

Publication Publication Date Title
KR100730527B1 (ko) 히알루론산 겔 조성물과 그의 제조방법 및 그것을함유하는 의용 재료
US20230226098A1 (en) Adhesion-preventing agent and method for preventing adhesion using same
KR101610268B1 (ko) 외과용 하이드로겔
DE69838614T2 (de) Zusammensetzungen von Carboxypolysaccharid-Polyetherkomplexen zur Verwendung zum Vermindern chirurgischer Verwachsungen
CN100398159C (zh) 水溶性纤维素醚化衍生物止血材料
US9220676B2 (en) Injectable in-situ crosslinked hydrogel and methods of making and using thereof
JPWO2015099083A1 (ja) 血清および血液を固化する水分散液
BRPI0612034A2 (pt) método para recuperar polìmero de quitina parcialmente desacetilado totalmente solúvel e elevadamente puro, composição de polìmero de quitina parcialmente desacetilado, e, composição farmacêutica
US20190194359A1 (en) Hemostatic Devices with Improved Properties and Methods of Making Same
JP2000237294A (ja) ヒアルロン酸ゲルを含有する医用材料
CN107029282A (zh) 一种温敏性医用壳聚糖衍生物制剂及其制备方法
JP2752782B2 (ja) 可溶性止血織物
WO2020181015A1 (en) System and method to reduce tissue or organ adhesion
CN104389155A (zh) 一种医用材料及制备方法
CN104307031B (zh) 一种皮肤外用修复材料的制备方法及用途
CN109589446A (zh) 一种可吸收生物止血材料及其制备方法
KR20210025918A (ko) 개선된 하이드로젤 지혈제 제조방법 및 그에 따른 지혈제
CN106975098A (zh) 一种复合多糖止血组合物及其制备方法与应用
HK40083605A (en) Adhesion-preventing agent and method for preventing adhesion using same
CN107405420A (zh) 经改良羧甲基纤维素及其制备方法
TW202411260A (zh) 製造自體交聯透明質酸凝膠之方法及其產物
CN107715167A (zh) 作为骨蜡替代物的壳聚糖基止血糊剂及制备方法
JP2010035744A (ja) 癒着防止材
JP2003019194A (ja) ヒアルロン酸とカルボキシメチルセルロースからなる共架橋ゲル組成物
US20190388458A1 (en) Medicament containing modified starch for the treatment of anastomoses

Legal Events

Date Code Title Description
W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251117

U13 Renewal or maintenance fee not paid

Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE

Effective date: 20260119

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260204